Pityriasis Rubra Pilaris
📧 Sign up to get email alerts when something new happens for Pityriasis Rubra Pilaris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris [Phase 2]
Phase 2 clinical trial update for Deucravacitinib in pityriasis rubra pilaris. The study is currently recruiting.